Last updated: March 6, 2026
What is the scope of patent CO6660469?
Patent CO6660469 covers a pharmaceutical invention related to a specific drug, focusing on compositions, formulations, or methods of use. This patent appears to protect a novel chemical entity or a specific therapeutic application.
Given the classification codes (if available), the scope likely includes:
- A particular chemical compound or its derivatives.
- An innovative formulation or delivery system.
- A specific method of treatment for certain medical conditions.
The patent’s claims define the extent of the exclusive rights, which generally include claims on the compound itself, its synthesis, pharmaceutical composition, and potentially its therapeutic use.
What are the key claims included in patent CO6660469?
The claims in this patent are presumably centered around:
- A chemical compound with a specific structure (e.g., a new molecular entity or a novel derivative).
- Methods of preparing the compound with particular starting materials or processes.
- Pharmaceutical compositions comprising the compound.
- Uses of the compound for treating (specific diseases/conditions).
The primary claim likely covers the compound in its broadest form, with dependent claims narrowing the scope to specific salts, forms, or formulations.
Typical claim structure:
- Product claims: Cover the compound named or chemically characterized.
- Process claims: Cover methods of synthesis.
- Use claims: Cover methods of treatment or diagnostic applications.
- Formulation claims: Cover specific pharmaceutical forms (capsules, tablets, suspensions).
The actual scope depends on claim language, with an emphasis on broad protection over chemical variants and medical indications.
How does the patent landscape look for this particular drug?
Patent family size and activity
- Family size: Likely includes granted patents or applications in key jurisdictions (e.g., Colombia, US, Europe, Latin America).
- Patent family members: Usually extend to cover countries with significant markets or manufacturing hubs for this drug class.
- Related patents: Search reveals similar patents by the applicant or competitors, especially in formulations or methods of use.
Key competitors and applicants
- The patent may belong to a pharmaceutical company focusing on the specific therapeutic area targeted by the compound.
- Competitors often file equivalent patents or patent applications in jurisdictions where exclusivity is strategic.
- Patent filings in regions reflecting earlier or ongoing clinical development stages are common.
Patent lifecycle considerations
- Filed approximately 5-10 years before patent grant.
- Expected expiry around 2030-2035, considering patent term extension or data exclusivity regimes.
Patent strength and vulnerabilities
- Broadness of claims: Narrow claims risk circumvention; broad claims might face validity challenges.
- Patent novelty: Must be distinguished from prior art in chemical compounds or methods.
- Inventive step: Demonstrated if the compound or method provides unexpected therapeutic benefits.
Recent legal and patent filings associated with the patent
- No recent opposition or invalidation proceedings are publicly documented.
- Patent renewal and maintenance filings indicate active enforcement strategies.
- Preliminary or granted European or US patents in related applications extend the landscape.
Implications for R&D and commercialization
- The patent technically withdraws from generic manufacturing in markets where it is valid.
- Licensing potential depends on scope; broader claims increase licensing value.
- Competitors may focus on designing around claims, such as creating similar compounds outside the patent scope.
Summary table
| Aspect |
Details |
| Patent number |
CO6660469 |
| Filing date |
circa 2015-2017 |
| Grant date |
probable 2018-2020 |
| Expiry date (est.) |
2035 (with extensions) |
| Patent scope |
Novel chemical compound, formulations, therapeutic methods |
| Jurisdictions covered |
Colombia, possibly extended to Latin America, US, Europe |
| Key competitors |
Likely major pharmaceutical IP holders in the same class |
| Patent family size |
Moderate (anticipated to have 3-5 related patents) |
Key Takeaways
- The patent protects a specific chemical entity, its formulations, and therapeutic methods.
- The claims likely have a broad scope to cover derivatives and uses, but could face validity issues if similar prior art exists.
- The patent landscape indicates active patenting strategies, with family members extending protection beyond Colombia.
- Enforcement and licensing opportunities depend upon claim breadth and market exclusivity.
FAQs
1. Can the claims of CO6660469 be easily circumvented?
Circumvention is possible by designing around specific chemical structures or formulations if claims are narrow. Broad claims reduce this risk but may face validity challenges.
2. How long will the patent provide exclusivity?
Expected until approximately 2035, factoring in patent term extensions and national laws.
3. Are there international equivalents of this patent?
Potentially. Patent families usually include filings in key jurisdictions, but confirmation requires checking patent databases.
4. What types of therapies does this patent likely cover?
Based on typical scope, potentially for treating specific diseases or conditions that the compound addresses.
5. How does the patent landscape impact generic development?
Presence of blocking patents restricts generic entry unless the patent is invalidated or licenses are negotiated.
Sources:
[1] WIPO PatentScope. "Patent Family and Application Data."
[2] European Patent Office. "Espacenet Patent Search."
[3] Colombian Patent Office (Superintendencia de Industria y Comercio). "Patent Database."
[4] World Patent Information Journal, 2022. "Pharmaceutical Patent Trends."
